- Home
- SPTX vs DXYZ Comparison
SPTX vs DXYZ Comparison
Compare SPTX & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPTX | DXYZ |
|---|---|---|
| Founded | 2024 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 929.8M | 974.9M |
| IPO Year | 2026 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPTX | DXYZ |
|---|---|---|
| Price | $20.41 | $27.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | 184.4K | ★ 728.2K |
| Earning Date | 11-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.79 | $19.71 |
| 52 Week High | $28.38 | $72.87 |
Technical Indicators
Market Signals| Indicator | SPTX | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.59 | 38.88 |
| Support Level | $18.72 | $24.16 |
| Resistance Level | $22.75 | $29.88 |
| Average True Range (ATR) | 1.28 | 1.33 |
| MACD | 0.52 | -0.29 |
| Stochastic Oscillator | 90.07 | 21.32 |
Price Performance
Historical ComparisonAbout SPTX Seaport Therapeutics Inc. Common Stock
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
About DXYZ Destiny Tech100 Inc.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.